![Louis Lange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 78 138 $ in data 31/05/2026
Dr. Louis G.
Lange is an Independent Director at Enterprise 4.0 Technology Acquisition Corp., an Independent Non-Executive Director at NewAmsterdam Pharma Co. NV, an Independent Director at Epiphany Technology Acquisition Corp., an Independent Director at BioPlus Acquisition Corp., an Independent Director at Stealth BioTherapeutics Corp., an Executive Chairman at Amygdala Neurosciences, Inc. and a Partner at Asset Management Ventures LLC.
He is on the Board of Directors at Enterprise 4.0 Technology Acquisition Corp., NewAmsterdam Pharma Co. NV, Epiphany Technology Acquisition Corp., BioPlus Acquisition Corp., DiNAQOR AG, Revitope Oncology, Inc., Teon Therapeutics, Inc., Stealth BioTherapeutics Corp., Maverix Biomics, Inc., InCarda Therapeutics, Inc., Recardia Therapeutics, Inc., University of Rochester, NewAmsterdam Pharma BV and NewAmsterdam Pharma Holding BV.
He received his undergraduate degree from the University of Rochester, a graduate degree from Harvard University and a doctorate degree from Harvard University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2026 | 2.320 ( 0% ) | 78 138 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENTERPRISE 4.0 TECHNOLOGY ACQUISITION CORP. | Direttore/Membro del Consiglio | 21/04/2023 |
| BIOPLUS ACQUISITION CORP. | Direttore/Membro del Consiglio | 01/12/2021 |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Direttore/Membro del Consiglio | 01/11/2022 |
| EPIPHANY TECHNOLOGY ACQUISITION CORP. | Direttore/Membro del Consiglio | 23/09/2022 |
| STEALTH BIOTHERAPEUTICS CORP | Direttore/Membro del Consiglio | 24/07/2019 |
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Engages in research and development of transformative therapies for cardio metabolic diseases | Direttore/Membro del Consiglio | - |
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat dyslipidemia | Direttore/Membro del Consiglio | - |
Recardia Therapeutics, Inc. | Direttore/Membro del Consiglio | - |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology Develops transforming cardiovascular disease treatment through pulmonary delivery of established drugs | Direttore/Membro del Consiglio | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 35 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Synecor LLC
 Synecor LLC Investment ManagersFinance Synecor invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in early-stage transactions. | Finance |
CardioDx, Inc.
 CardioDx, Inc. Medical/Nursing ServicesHealth Services Operates as a cardiovascular genomic diagnostics company | Health Services |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Cardiogen Sciences, Inc.
 Cardiogen Sciences, Inc. Pharmaceuticals: GenericHealth Technology Develops adeno-associated virus gene therapy products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VantagePoint Management, Inc.
 VantagePoint Management, Inc. Investment ManagersFinance VantagePoint invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Institute for Systems Biology
 Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Provides integration of technology, computation, biology and medicine | Commercial Services |
Jewish Hospital
 Jewish Hospital Hospital/Nursing ManagementHealth Services Operates a hospital | Health Services |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology Develops transforming cardiovascular disease treatment through pulmonary delivery of established drugs | Health Technology |
Rapidscan Pharma Solutions, Inc.
 Rapidscan Pharma Solutions, Inc. Medical/Nursing ServicesHealth Services Provides novel technologies for the diagnosis of disease | Health Services |
Asset Management Ventures LLC
 Asset Management Ventures LLC Investment ManagersFinance AMV invests in companies located in the United States. The firm focuses on digital health, information technology and life sciences sectors. It participates in seed, early and late stage capital transactions | Finance |
Maverix Biomics, Inc.
 Maverix Biomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cloud-based platform to manage, analyze and visualize genomic data | Commercial Services |
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat dyslipidemia | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Gladstone Foundation (CA)
 Gladstone Foundation (CA) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit life science research organization that focuses on biomedical and technological fields | Commercial Services |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amygdala Neurosciences, Inc.
 Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmacotherapies to treat substance use disorder | Health Technology |
Revitope Oncology, Inc.
 Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Teon Therapeutics, Inc.
 Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing molecule drugs for cancer immunotherapy, cardiovascular and metabolic diseases | Commercial Services |
DiNAQOR AG
 DiNAQOR AG BiotechnologyHealth Technology Develops gene therapy solutions | Health Technology |
Epiphany Technology Acquisition Corp.
 Epiphany Technology Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
NewAmsterdam Pharma Holding BV
NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Engages in research and development of transformative therapies for cardio metabolic diseases | Health Technology |
BioPlus Acquisition Corp.
 BioPlus Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Recardia Therapeutics, Inc. | |
Enterprise 4.0 Technology Acquisition Corp.
 Enterprise 4.0 Technology Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Bitterroot Bio, Inc.
 Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Health Technology |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
